000			01576 a2200433 4500
005			20250513125132.0
264		0	_c19971008
008			199710s 0 0 eng d
022			_a0022-2623
024	7		_a10.1021/jm970283e _2doi
040			_aNLM _beng _cNLM
100	1		_aFang, X
245	0	0	_a7-spirobenzocyclohexyl derivatives of naltrexone, oxymorphone, and hydromorphone as selective opioid receptor ligands. _h[electronic resource]
260			_bJournal of medicinal chemistry _cSep 1997
300			_a3064-70 p. _bdigital
500			_aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aElectric Stimulation
650	0	4	_aGuinea Pigs
650	0	4	_aHydromorphone _xanalogs & derivatives
650	0	4	_aIn Vitro Techniques
650	0	4	_aLigands
650	0	4	_aMale
650	0	4	_aMice
650	0	4	_aMolecular Conformation
650	0	4	_aMolecular Structure
650	0	4	_aMuscle Contraction _xdrug effects
650	0	4	_aMuscle, Smooth _xdrug effects
650	0	4	_aNaltrexone _xanalogs & derivatives
650	0	4	_aNarcotics _xchemical synthesis
650	0	4	_aOxymorphone _xanalogs & derivatives
650	0	4	_aReceptors, Opioid, delta _xagonists
650	0	4	_aSpiro Compounds _xchemical synthesis
650	0	4	_aStructure-Activity Relationship
700	1		_aLarson, D L
700	1		_aPortoghese, P S
773	0		_tJournal of medicinal chemistry _gvol. 40 _gno. 19 _gp. 3064-70
856	4	0	_uhttps://doi.org/10.1021/jm970283e _zAvailable from publisher's website
999			_c9280057 _d9280057